Streetbeat News

MEDS

TRxADE HEALTH, Inc.

https://www.trxadehealth.com

Industry

Medical - Pharmaceuticals

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.

Open

7.25

Mkt cap

13M

Volume

19K

High

7.70

P/E Ratio

-0.31

52-wk high

44.56

Low

7.06

Div yield

1.25

52-wk low

3.69

TRxADE HEALTH shares are trading lower, pulling back from the strength they showed on Wednesday.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:06 pm

Numerous stocks experienced significant price changes in Thursday's mid-day session. Companies that posted strong quarterly results, such as Traeger, Inc. (COOK), Upwork Inc. (UPWK), and The Clorox Company (CLX), saw their shares rise. Conversely, companies that reported worse-than-expected results or issued below-consensus outlooks, such as DXC Technology Company (DXC), Expedia Group, Inc. (EXPE), and Cummins Inc. (CMI), saw their shares fall.

Portfolio Pulse from Lisa Levin

August 04, 2023 | 1:56 pm

Shares of TRxADE HEALTH are trading higher on abnormally-high volume without any company-specific news to justify the price action.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 11:56 am

During Wednesday's intraday session, several healthcare stocks experienced significant movements. Trxade Health (MEDS), Advanced Health (AHI), Applied Therapeutics (APLT), TC BioPharm (TCBP), TRACON Pharma (TCON), and Frequency Therapeutics (FREQ) saw their shares rise, with Trxade Health leading the gainers with a 63.3% increase. On the other hand, Adamis Pharmaceuticals (ADMP), Aptevo Therapeutics (APVO), Biophytis (BPTS), Nevro (NVRO), SmileDirectClub (SDC), and Bio-Path Hldgs (BPTH) experienced declines, with Adamis Pharmaceuticals leading the losers with a 63.4% decrease.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 11:51 am

Trading of TRxADE HEALTH shares has resumed.

Portfolio Pulse from Happy Mohamed

August 04, 2023 | 11:29 am

Shares of TRxADE HEALTH (MEDS) were halted on a circuit breaker to the downside, but resumed trading and are now up 69.8%.

Portfolio Pulse from Happy Mohamed

August 04, 2023 | 11:28 am

TRxADE Health, Inc. (NASDAQ:MEDS) announced the closing of the acquisition of Superlatus, Inc. on Monday. As a result, MEDS shares are up by more than 45% on heavy trading volume. The company will report its Q2 financial results on Aug. 14.

Portfolio Pulse from Erica Kollmann

August 04, 2023 | 11:27 am

Shares of TRxADE HEALTH were halted on a circuit breaker due to a sharp increase in price. The stock is now up by 73.6%.

Portfolio Pulse from Happy Mohamed

August 04, 2023 | 11:25 am

The Dow Jones fell over 100 points, with NASDAQ and S&P 500 also experiencing drops. Phillips 66 reported better-than-expected Q2 results, with an EPS of $3.87 and revenue of $35.74 billion. WaveDancer, T Stamp, and TRxADE HEALTH saw significant stock increases, while Adamis Pharmaceuticals, Cambium Networks, and Latch experienced drops. Adamis announced the pricing of an $8 million public offering, Cambium reported worse-than-expected Q2 results, and Latch does not anticipate regaining compliance with its periodic filing obligations before its deadline.

Portfolio Pulse from Lisa Levin

August 04, 2023 | 11:22 am

In Wednesday's pre-market session, several health care stocks showed significant movement. Trxade Health (MEDS), Advanced Health (AHI), Abeona Therapeutics (ABEO), MiMedx Group (MDXG), KalVista Pharma (KALV), and China SXT Pharmaceuticals (SXTC) saw gains, while Adamis Pharmaceuticals (ADMP), Aptevo Therapeutics (APVO), Meihua Intl Medical Techs (MHUA), Femasys (FEMY), Eledon Pharma (ELDN), and Silk Road Medical (SILK) experienced losses. MiMedx Group and Silk Road Medical released their Q2 earnings reports.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 11:16 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.